A patient with type 2 diabetes presents with diminished sensation in the lower extremities, signs of non-proliferative diabetic retinopathy, and an elevated urine microalbumin-to-creatinine ratio. Which initial nursing intervention is most important to address these findings and prevent further complications?

B) Educate the patient on the importance of daily foot inspections.

A) Encourage the patient to increase dietary protein intake.

B) Educate the patient on the importance of daily foot inspections.

C) Schedule regular ophthalmology appointments every year.

D) Initiate a high-intensity exercise program.

A patient with diabetes is experiencing diminished sensation in the lower extremities and signs of non-proliferative diabetic retinopathy. Her laboratory results show an elevated hemoglobin A1c and a high urine microalbumin-to-creatinine ratio. Which intervention should the nurse prioritize to address the patient's condition and prevent further complications?

A) Educate the patient on the importance of regular foot inspections and proper footwear.

B) Recommend the patient increase her dietary protein intake to support kidney health.

C) Suggest the patient engage in high-intensity exercise to improve glucose control.

D) Encourage the patient to limit fluid intake to reduce kidney workload.

A patient with hypertension and type 2 diabetes mellitus has been started on an ACE inhibitor to improve blood pressure control and provide renal protection. Upon her follow-up visit, she reports persistent fatigue and dizziness. Which nursing intervention is most appropriate at this time?

B) Instruct the patient to monitor her blood pressure regularly and report any significant hypotension.

A) Advise the patient to increase her fluid intake to counteract potential dehydration.

B) Instruct the patient to monitor her blood pressure regularly and report any significant hypotension.

C) Recommend the patient to reduce her exercise regimen to minimize fatigue.

D) Suggest the patient to take her ACE inhibitor at night to reduce daytime dizziness.

A patient with a history of hypertension and diabetes mellitus type 2 has been started on an ACE inhibitor to improve blood pressure control and provide renal protection. She reports persistent fatigue and occasional dizziness during her follow-up visit. Which nursing intervention is most appropriate to address these symptoms and ensure effective management of her condition?

D) Suggest the patient monitor her blood pressure before taking the ACE inhibitor to prevent hypotension.

A) Advise the patient to increase dietary sodium to combat dizziness.

B) Instruct the patient to take her blood pressure medication at night to reduce side effects.

C) Encourage the patient to maintain a consistent exercise routine to reduce fatigue.

D) Suggest the patient monitor her blood pressure before taking the ACE inhibitor to prevent hypotension.

A patient with Type 2 Diabetes Mellitus has been experiencing increased nighttime urination, tingling in her feet, and recent elevation in serum creatinine levels. She is currently on an ACE inhibitor for blood pressure management. Which nursing action is most appropriate to address her current symptoms and potential complications?

A) Educate the patient on the importance of daily foot inspections and proper footwear.

B) Advise the patient to increase her water intake to manage nighttime urination.

C) Suggest the patient reduce her ACE inhibitor dose to minimize renal function impact.

D) Encourage the patient to monitor her blood glucose levels more frequently to prevent hyperglycemia.

A patient with type 2 diabetes and hypertension is experiencing new symptoms of tingling in her feet and increased nighttime urination. Her laboratory results show a decreased hemoglobin A1c, but an increased urine microalbumin-to-creatinine ratio and elevated serum creatinine level. Which nursing intervention is most appropriate to prioritize in her care plan?

A) Educate the patient on the importance of maintaining a blood pressure below 140/90 mmHg to protect renal function.

B) Instruct the patient on proper foot care techniques to prevent complications from neuropathy.

C) Encourage the patient to monitor her blood glucose levels more frequently to maintain optimal glycemic control.

D) Discuss the potential need for dialysis should her renal function continue to decline.

A patient with diabetic nephropathy presents with mild swelling in the lower extremities and elevated blood pressure. Which nursing intervention should be prioritized to manage this patient's condition effectively?

B) Instruct the patient on the importance of adhering to a low-sodium diet.

A) Encourage the patient to increase fluid intake to promote kidney function.

B) Instruct the patient on the importance of adhering to a low-sodium diet.

C) Recommend the patient to engage in regular high-impact exercises to reduce edema.

D) Advise the patient to decrease the frequency of blood glucose monitoring.

A patient with Type 2 Diabetes Mellitus presents with persistent fatigue, mild swelling in the lower extremities, and increased tingling in the feet. Laboratory results indicate worsening renal function with a urine microalbumin-to-creatinine ratio of 85 mg/g and serum creatinine level of 1.6 mg/dL. Which nursing intervention is most critical to prioritize for this patient?

B) Educate the patient on sodium restriction to manage fluid retention.

A) Encourage increased fluid intake to prevent dehydration.

B) Educate the patient on sodium restriction to manage fluid retention.

C) Advise the patient to increase physical activity to improve circulation.

D) Recommend the use of compression stockings to reduce swelling.

A patient with diabetes has been prescribed a loop diuretic and is experiencing neuropathic pain symptoms. Given the current case, which nursing intervention would best address the patient's neuropathic symptoms while considering her overall condition?

D) Educate the patient about the potential benefits of prescribed neuropathic pain medication.

A) Encourage increased fluid intake to counteract the diuretic's effect.

B) Recommend a comprehensive foot care routine to prevent further neuropathic complications.

C) Suggest the use of over-the-counter pain medications to manage tingling sensations.

D) Educate the patient about the potential benefits of prescribed neuropathic pain medication.

A patient with diabetes and renal impairment is experiencing neuropathic pain despite starting a loop diuretic for fluid retention. What would be the most appropriate nursing intervention to address her neuropathic symptoms while considering her overall condition?

C) Encourage the patient to discuss the use of a medication like gabapentin with her healthcare provider.

A) Recommend the patient increase her walking to improve circulation.

B) Suggest the patient take over-the-counter acetaminophen for pain relief.

C) Encourage the patient to discuss the use of a medication like gabapentin with her healthcare provider.

D) Advise the patient to reduce her fluid intake to alleviate neuropathic pain.

diabetic - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin deficiency or resistance leads to impaired glucose uptake by cells, causing hyperglycemia. As a result, cells are deprived of energy while blood glucose levels rise, leading to various systemic effects.

• Secondary mechanism: Chronic hyperglycemia triggers the polyol pathway, where excess glucose is converted to sorbitol, causing osmotic and oxidative stress in cells, particularly affecting nerves and vascular tissues.

• Key complication: Persistent high blood glucose levels cause damage to blood vessels (microvascular complications like retinopathy, nephropathy) and nerves (neuropathy), increasing the risk of cardiovascular diseases and other long-term complications.

Patient Profile

Demographics:

56-year-old female, office manager

History:

• Key past medical history: Type 2 diabetes diagnosed 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg daily, Atorvastatin 20 mg daily, Aspirin 81 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and tingling in the feet

• Key symptoms: Blurred vision, occasional dizziness, intermittent numbness in toes, increased thirst

• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose 180 mg/dL (fasting)

Section 1

During her follow-up appointment, further assessment and diagnostic work were conducted to evaluate the progression of her diabetic complications. Physical examination revealed diminished sensation in the lower extremities, particularly in the toes, using a monofilament test, suggesting peripheral neuropathy. In addition, an ophthalmologic evaluation highlighted signs of non-proliferative diabetic retinopathy, as evidenced by microaneurysms and hemorrhages on retinal imaging. These findings indicate the impact of chronic hyperglycemia on her microvascular system, warranting immediate attention to prevent further deterioration.

Laboratory tests were ordered to assess the extent of her metabolic control and potential renal involvement. Her hemoglobin A1c returned at 8.5%, indicating suboptimal long-term glucose control. Additionally, her urine microalbumin-to-creatinine ratio was elevated at 40 mg/g, suggesting early-stage diabetic nephropathy. This lab result is crucial, as it reflects the beginning of kidney involvement, which, if unaddressed, could progress to more severe renal impairment.

Given the combination of neuropathy, retinopathy, and early nephropathy, the patient's treatment plan needs to be adjusted to better control her blood glucose levels and minimize further complications. This includes reinforcing lifestyle modifications, considering adjustments in her medication regimen, such as the potential addition of a GLP-1 receptor agonist or SGLT2 inhibitor to improve glycemic control and provide renal protection. The healthcare team must work closely with the patient to enhance adherence to her therapeutic plan, monitor her response to interventions, and prevent further decline in her health status.

Section 2

Following the adjustment in her treatment plan, the patient was scheduled for a follow-up appointment after three months to assess her response to the interventions. During this visit, her vital signs were stable, but she reported persistent fatigue and occasional dizziness. On physical examination, her blood pressure was measured at 145/90 mmHg, slightly higher than her previous readings, indicating potential challenges in managing her hypertension. Her weight had remained stable, and she continued to adhere to the recommended dietary and exercise regimen.

Laboratory tests revealed a modest improvement in glycemic control, with her hemoglobin A1c reduced to 7.9%. However, her urine microalbumin-to-creatinine ratio had slightly increased to 45 mg/g, suggesting a need for more aggressive management of her renal risk factors. The healthcare team noted that while the addition of a GLP-1 receptor agonist had contributed to better blood glucose levels, further adjustments were necessary to address her blood pressure and protect her kidney function.

Given these findings, the team decided to introduce an ACE inhibitor to her medication regimen, aiming to provide additional renal protection and improve her blood pressure control. The patient was advised to monitor her blood pressure at home regularly and report any significant changes. This approach required careful coordination to ensure that her overall therapeutic plan was optimized and that she understood the importance of medication adherence and lifestyle modifications in preventing further complications. The team emphasized the need for ongoing monitoring and education to empower the patient in managing her chronic condition effectively.

Section 3

Three months later, the patient returned for her scheduled follow-up appointment. During the initial assessment, she reported a noticeable reduction in her dizziness, although fatigue persisted. Her blood pressure readings at home fluctuated but showed an overall downward trend since the introduction of the ACE inhibitor. At the clinic, her blood pressure was recorded at 138/85 mmHg, indicating a slight improvement. Despite this progress, she expressed concern about new symptoms: occasional tingling in her feet and increased frequency of urination, particularly at night.

Laboratory tests were ordered to investigate these new symptoms. The results revealed a further reduction in her hemoglobin A1c to 7.5%, suggesting continued improvement in her glycemic control. However, her urine microalbumin-to-creatinine ratio had increased to 60 mg/g, indicating worsening renal function. Additionally, her serum creatinine levels were slightly elevated at 1.4 mg/dL, compared to her baseline of 1.1 mg/dL. These changes prompted the healthcare team to suspect the early stages of diabetic nephropathy, necessitating an urgent review of her current treatment plan.

The team discussed the importance of maintaining optimal blood pressure and blood glucose levels to slow the progression of renal impairment. They decided to increase the dosage of the ACE inhibitor and referred her to a nephrologist for further evaluation. The patient was educated on the symptoms of neuropathy and the significance of foot care in diabetes management. This comprehensive approach underscored the need for vigilant monitoring of her condition and a collaborative effort to prevent further complications. As the patient left the clinic, she was reminded of the importance of keeping all follow-up appointments and maintaining open communication with her healthcare team.

Section 4

Three months after her last visit, the patient returned for another follow-up appointment. During the initial assessment, she reported persistent fatigue and a new symptom: mild swelling in her lower extremities. She noted that the tingling sensation in her feet had become more pronounced, occasionally affecting her daily activities. Her blood pressure at the clinic was recorded at 142/88 mmHg, a slight increase from her previous visit. Her weight had also increased by 3 pounds, and she mentioned a decrease in her physical activity due to the discomfort in her feet.

New laboratory tests were conducted to evaluate these changes. Her hemoglobin A1c had improved marginally to 7.2%, demonstrating continued but slow progress in glycemic control. However, her urine microalbumin-to-creatinine ratio had risen to 85 mg/g, and her serum creatinine level increased to 1.6 mg/dL, indicating further deterioration in renal function. These findings, coupled with the swelling in her legs, raised concerns about fluid retention and possible exacerbation of her diabetic nephropathy.

The healthcare team, recognizing the progression of her renal impairment, decided to initiate a loop diuretic to address fluid overload and referred her to a nephrologist for immediate evaluation and management. The patient was counseled on the importance of adhering to dietary recommendations, particularly sodium restriction, to help manage her symptoms. Additional emphasis was placed on the importance of blood glucose control and regular foot examinations to prevent further neuropathic complications. The patient left the clinic with a reinforced understanding of her condition and a renewed commitment to engaging with her healthcare team to manage her diabetes and its complications effectively.

Section 5

Two weeks after initiating the loop diuretic, the patient returned to the clinic for a follow-up appointment. She reported a noticeable reduction in leg swelling and a slight improvement in her overall energy levels. However, she continued to experience significant tingling and burning sensations in her feet, which occasionally disrupted her sleep. During the physical examination, her blood pressure had decreased to 135/82 mmHg, suggesting some effectiveness of the diuretic in managing her fluid retention. Her weight had stabilized, and she noted being able to slowly resume her daily walks, albeit with some discomfort.

New laboratory tests revealed a slight improvement in her serum creatinine level, now at 1.5 mg/dL, indicating a modest stabilization of her renal function. However, her urine microalbumin-to-creatinine ratio remained elevated at 80 mg/g, signaling persistent renal stress. Her fasting blood glucose levels showed a marginal decline, averaging around 140 mg/dL, reflecting some benefit from her improved adherence to dietary modifications and medication regimen. Despite these positive changes, the persistent neuropathic symptoms prompted the healthcare team to consider the addition of a neuropathic pain medication to her treatment plan.

Recognizing the complexity of her condition, the healthcare team emphasized the importance of continued monitoring and proactive management of her diabetes and its complications. They reinforced the need for regular nephrology consultations to closely monitor her kidney function and the potential adjustment of her diuretic therapy. The patient was encouraged to maintain her commitment to lifestyle changes, including dietary modifications and consistent physical activity, to support her long-term health. As she left the clinic, the patient expressed appreciation for the comprehensive care and felt optimistic about her ability to manage her condition with the support of her healthcare team.